Stock & Company Details
DiaMedica Therapeutics Inc $DMAC
Price:
N/A
N/A
54M
$364M
52 Week High:
N/A
10 Day Average Volume:
N/A
-9.05
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
DMAC technical indicators
Latest DiaMedica Therapeutics Inc (DMAC) indicator readings as of 2026-08-28.
DMAC's 14-day RSI is 41.4, in neutral territory. At $6.39 it is trading 11.2% below its 200-day moving average of $7.19, and below its 50-day average of $6.86. Price sits below the lower Bollinger Band ($6.41 to $6.91). ADX reads 10.4, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.
Finance Bot
Ask your questions
Start by typing a question below.
